Cargando…

Molecular mechanism of Danshenol C in reversing peritoneal fibrosis: novel network pharmacological analysis and biological validation

OBJECTIVE: The primary objective of this study is to elucidate the molecular mechanism underlying the reversal of peritoneal fibrosis (PF) by Danshenol C, a natural compound derived from the traditional Chinese medicine Salvia miltiorrhiza. By comprehensively investigating the intricate interactions...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Jiabin, Cheng, Lulu, Feng, Jie, Han, Zeping, Huang, Chen, Xie, Fangmei, Li, Yongsheng, Luo, Xun, Wang, Qingmei, He, Jinhua, Chen, Hanwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571429/ https://www.ncbi.nlm.nih.gov/pubmed/37833759 http://dx.doi.org/10.1186/s12906-023-04170-x

Ejemplares similares

Progress in the application of body fluid and tissue level mRNAs-non-coding RNAs for the early diagnosis and prognostic evaluation of systemic lupus erythematosus
por: Liang, Jiabin, et al.
Publicado: (2022)

Danshenol A Alleviates Hypertension-Induced Cardiac Remodeling by Ameliorating Mitochondrial Dysfunction and Suppressing Reactive Oxygen Species Production
por: Chen, Kai, et al.
Publicado: (2019)

Danshenol A inhibits TNF-α-induced expression of intercellular adhesion molecule-1 (ICAM-1) mediated by NOX4 in endothelial cells
por: Zhao, Wenwen, et al.
Publicado: (2017)

Integration of molecular docking, molecular dynamics and network pharmacology to explore the multi‐target pharmacology of fenugreek against diabetes
por: Luo, Wenfeng, et al.
Publicado: (2023)

Therapeutic mechanism of baicalein in peritoneal dialysis-associated peritoneal fibrosis based on network pharmacology and experimental validation
por: Lu, Xiaohui, et al.
Publicado: (2023)

Research progress on application of single-cell TCR/BCR sequencing technology to the tumor immune microenvironment, autoimmune diseases, and infectious diseases
por: He, Jinhua, et al.
Publicado: (2022)

Serum organic acid metabolites can be used as potential biomarkers to identify prostatitis, benign prostatic hyperplasia, and prostate cancer
por: He, Jinhua, et al.
Publicado: (2023)

circSPECC1 Promotes Proliferation and Migration of LNCaP Prostate Cancer Cells by Affecting Their Epithelial-Mesenchymal Transition
por: Xie, Fangmei, et al.
Publicado: (2023)

Network pharmacology and bioinformatics were used to construct a prognostic model and immunoassay of core target genes in the combination of quercetin and kaempferol in the treatment of colorectal cancer
por: Gu, Chenqiong, et al.
Publicado: (2023)

New Developments in Peritoneal Fibroblast Biology: Implications for Inflammation and Fibrosis in Peritoneal Dialysis
por: Witowski, Janusz, et al.
Publicado: (2015)

Pharmacologic Inhibition of Histone Deacetylase 6 Prevents the Progression of Chlorhexidine Gluconate-Induced Peritoneal Fibrosis by Blockade of M2 Macrophage Polarization
por: Shi, Yingfeng, et al.
Publicado: (2022)

Autophagy in peritoneal fibrosis
por: Su, Hong-yong, et al.
Publicado: (2023)

Treatment of Gout with TCM Using Turmeric and Corn Silk: A Concise Review Article and Pharmacology Network Analysis
por: Zhang, Haoyu, et al.
Publicado: (2022)

Circular RNAs and Their Role in Exosomes
por: Han, Zeping, et al.
Publicado: (2022)

Effects of Noninvasive Brain Stimulation Combined With Antidepressants in Patients With Poststroke Depression: A Systematic Review and Meta-Analysis
por: Liang, Jiabin, et al.
Publicado: (2022)

Rapid and sensitive identification of pleural and peritoneal infections by droplet digital PCR
por: Zhou, Fangmei, et al.
Publicado: (2020)

Single‐cell transcriptomics provides new insights into the role of fibroblasts during peritoneal fibrosis
por: Zhang, Jinhua, et al.
Publicado: (2021)

Exploring the Mechanism of Dangguiliuhuang Decoction Against Hepatic Fibrosis by Network Pharmacology and Experimental Validation
por: Cao, Hui, et al.
Publicado: (2018)

Network pharmacology combined with molecular docking and experimental validation to reveal the pharmacological mechanism of naringin against renal fibrosis
por: Zhong, Yanan, et al.
Publicado: (2023)

circMSH3 is a potential biomarker for the diagnosis of colorectal cancer and affects the distant metastasis of colorectal cancer
por: Shen, Jian, et al.
Publicado: (2023)

Myocardial fibrosis reversion via rhACE2-electrospun fibrous patch for ventricular remodeling prevention
por: Qiu, Zeping, et al.
Publicado: (2021)

Analysis of the potential biological mechanisms of diosmin against renal fibrosis based on network pharmacology and molecular docking approach
por: Zhao, Wen-Man, et al.
Publicado: (2023)

The Gut-Peritoneum Axis in Peritoneal Dialysis and Peritoneal Fibrosis
por: Stepanova, Natalia
Publicado: (2023)

Integrating Network Pharmacology and Experimental Validation to Explore the Pharmacological Mechanism of Astragaloside IV in Treating Bleomycin-Induced Pulmonary Fibrosis
por: Yuan, Su, et al.
Publicado: (2023)

Deciphering the pharmacological mechanisms of Chaenomeles Fructus against rheumatoid arthritis by integrating network pharmacology and experimental validation
por: Sun, Mengjia, et al.
Publicado: (2022)

Mechanism of Yangxinshi Intervention on Cardiac Fibrosis in Diabetic Cardiomyopathy Based on Network Pharmacology
por: Kuang, Jiangying, et al.
Publicado: (2022)

The Role of Cathepsin B in Peritoneal Fibrosis due to Peritoneal Dialysis
por: Sung, Su Ah, et al.
Publicado: (2019)

Fibrosis of Peritoneal Membrane as Target of New Therapies in Peritoneal Dialysis
por: Masola, Valentina, et al.
Publicado: (2022)

The Role of Peritoneal Alternatively Activated Macrophages in the Process of Peritoneal Fibrosis Related to Peritoneal Dialysis
por: Wang, Jie, et al.
Publicado: (2013)

Expression of XBP1s in peritoneal mesothelial cells is critical for inflammation-induced peritoneal fibrosis
por: Liu, An, et al.
Publicado: (2019)

Mechanisms of Peritoneal Fibrosis: Focus on Immune Cells–Peritoneal Stroma Interactions
por: Terri, Michela, et al.
Publicado: (2021)

Inhibition of calpain9 attenuates peritoneal dialysis-related peritoneal fibrosis
por: Li, Fang, et al.
Publicado: (2022)

Dipeptidyl peptidase 4 promotes peritoneal fibrosis and its inhibitions prevent failure of peritoneal dialysis
por: Li, Yi-Chen, et al.
Publicado: (2021)

Blockade of prostaglandin E2 receptor 4 ameliorates peritoneal dialysis-associated peritoneal fibrosis
por: Luo, Qimei, et al.
Publicado: (2022)

Exploration of the potential mechanism of Baicalin for hepatic fibrosis based on network pharmacology, gut microbiota, and experimental validation
por: Liu, Sujie, et al.
Publicado: (2023)

Exploration on Molecular Mechanism of Reversal Effect of Compound Danshen Tablets on Hepatic Fibrosis Based on Network Pharmacology
por: Cao, Minling, et al.
Publicado: (2022)

Deciphering the Pharmacological Mechanisms of Qidan Dihuang Decoction in Ameliorating Renal Fibrosis in Diabetic Nephropathy through Experimental Validation In Vitro and In Vivo
por: Liang, Qiuer, et al.
Publicado: (2022)

Tamoxifen exerts anti-peritoneal fibrosis effects by inhibiting H19-activated VEGFA transcription
por: Zhao, Tingting, et al.
Publicado: (2023)

MicroRNA‐302c modulates peritoneal dialysis‐associated fibrosis by targeting connective tissue growth factor
por: Li, Xiejia, et al.
Publicado: (2019)

Galectin-1 promotes gastric cancer peritoneal metastasis through peritoneal fibrosis
por: Shen, Xianhe, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b30o9oi55g9qp275f42km7v92f